Abstract:Myricetin and its glycosides are important flavonols commonly found in plants, and they are natural organic compounds with diverse pharmacological activities. Numerous studies have demonstrated that myricetin and its glycosides are strong antioxidants that have great potential in preventing, alleviating and assisting the treatment of chronic non-infectious diseases such as cancer, diabetes, and cardiovascular diseases. In addition, myricetin and its glycosides also have antiviral, antibacterial, anti-inflammatory, analgesic, liver protection and other pharmacological activities. Myricetin contains more hydroxyl groups in the parent ring structure than other flavonoids, so myricetin and its glycosides have stronger pharmacological activities than other flavonols or flavonoids such as quercetin and kaempferol. Therefore, myricetin and its glycosides have great development and application prospects. In this paper, the classification and distribution of myricetin and its glycosides, their pharmacological activity and mechanism, as well as comparison with other flavonoids were reviewed. In addition, limitations of the current research and application of myricetin and its glycosides were analyzed, and the further studies on pharmacological activities as well as their dose-activity relationship, structure-activity relationship, chemical modification, biosynthesis and application prospects of myricetin and its glycosides were discussed and proposed.

Synthesis of Myricetin Derivatives and Evaluation of Their Hypoglycemic Activities

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Synthesis of 4-thiosubstituted flavan derivatives and their hypoglycemic activities

Synthesis,Characterization and Antidiabetic Activities of Novel Genipin Derivatives

Synthesis and Anti-Hyperglycemic Activity of Hesperidin Derivatives

[Pharmacological Activities of Myricetin and Its Glycosides].

Synthesis & Alpha-Glucosidase Inhibitory & Glucose Consumption-Promoting Activities O Flavonoid-Coumarin Hybrids

Synthesis and Evaluation of Coumarin-Chalcone Derivatives as α-Glucosidase Inhibitors

Hypoglycemic activity and mechanisms of myricetin

Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.

Synthesis and Evaluation of the Α-Glucosidase Inhibitory Activity of 3-[4-(phenylsulfonamido)benzoyl]-2h-1-benzopyran-2-one Derivatives

Synthesis and Α-Glucosidase Inhibitory Activity of Chrysin, Diosmetin, Apigenin, and Luteolin Derivatives

Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α‐glucosidase

Design, Synthesis and Biological Evaluation of Novel (E)-2-benzylidene-n-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide Derivatives As Α-Glucosidase Inhibitors.

Synthesis and Hypoglycemic Activity Evaluation of Rhein Amide Derivatives

Synthesis and in Vivo Acute Antihyperglycemic Evaluation of Novel Isosteviol Derivatives

Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.

Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents

Selective synthesis of 3-deoxy-5-hydroxy-1-amino-carbasugars as potential α-glucosidase inhibitors

Synthesis and hypoglycemic activity of sulfonaminothioureas and sulfonamino-cyanoguanidines

Synthesis of 6-Hydroxyaurone Analogues and Evaluation of Their Α-Glucosidase Inhibitory and Glucose Consumption-Promoting Activity: Development of Highly Active 5,6-Disubstituted Derivatives